Back to BR Brookstone Capital Management

TGTXTGTX

Showing 8 of 17 quarters

Position history for BRBrookstone Capital Management's holdings in TG Therapeutics, Inc.

Yes. Brookstone Capital Management holds 17,521 shares of TGTX (TG Therapeutics), worth $977,321, as of its Q3 2026 13F filing. The share count is unchanged from Q2 2026. Brookstone Capital Management has held TGTX since Q3 2022, across 17 quarterly 13F filings.

Current Value

$977,321

Current Shares

17,521

Total Value Change

+$449,939

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Unchanged
17,521
0.0%
$977,3210.0%$55.78
0
2026-Q2
Unchanged
17,521
0.0%
$962,6040.0%$54.94
0
2026-Q1
Unchanged
17,521
0.0%
$582,0480.0%$33.22
0
2025-Q4
Unchanged
17,521
0.0%
$522,3010.0%$29.81
0
2025-Q3
Unchanged
17,521
0.0%
$632,9460.0%$36.13
0
2025-Q2
Decreased
17,521
-0.5%
$630,5810.0%$35.99
0
2025-Q1
Increased
17,608
+0.5%
$694,2830.0%$39.43
25
2024-Q4
Increased
17,521
+3.7%
$527,3820.0%$30.10
25

Optional analytics helps us improve. How it’s used